MVA Investors, LLC's Net Worth
$101 Million
Who is MVA Investors, LLC?
MVA Investors, LLC has an estimated net worth of $101 Million. This is based on reported shares across multiple companies, which include SOPHIRIS BIO INC., iTeos Therapeutics, Inc., PMV Pharmaceuticals, Inc., Mirati Therapeutics, Inc., Tyra Biosciences, Inc., Tango Therapeutics, Inc., Solid Biosciences Inc., Eleven Biotherapeutics, Inc., Pandion Therapeutics, Inc., Rain Therapeutics Inc., Somaxon Pharmaceuticals, Inc., and ARADIGM CORP.
SEC CIK
MVA Investors, LLC's CIK is 0001468223
Past Insider Trading and Trends
2020 was MVA Investors, LLC's most active year for acquiring shares with 14 total transactions. MVA Investors, LLC's most active month to acquire stocks was the month of September. 2020 was MVA Investors, LLC's most active year for disposing of shares, totalling 14 transactions. MVA Investors, LLC's most active month to dispose stocks was the month of December. 2023 saw MVA Investors, LLC paying a total of $116,443,894.38 for 10,649,104 shares, this is the most they've acquired in one year. In 2020 MVA Investors, LLC cashed out on 19,115,448 shares for a total of $83,040,276.71, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SOPHIRIS BIO INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -34.41% | -881.48K |
$0.61 | -$537,702.19 | 1.68M |
Dec 15
| |||
Form 4
| +166.40% | 1.6M |
$5.00 | $8,000,000.00 | 2.56M |
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
iTeos Therapeutics, Inc. (ITOS) Snapshot price: $10.52
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.41% | -700.00K |
$45.32 | -$32,575,642.35 | 7.62M |
Jan 3 - Jan 4
| |||
Form 4
| +147.62% | 4.42M |
$19.00 | $27,075,000.00 | 7.41M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.33M |
$18.00 |
—
| 2.33M |
Sep 25 - Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Mirati Therapeutics, Inc. (MRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.86M |
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +56.45% | 1.26M |
$27.80 | $34,999,449.40 | 3.49M |
Aug 11
| |||
Form 4
| +56.45% | 1.26M |
$27.80 | $34,999,449.40 | 3.49M |
Aug 11
| |||
Form 4
| +10.47% | 211.44K |
$181.15 | -$72,460,293.56 | 2.23M |
Mar 5
| |||
Form 4
|
—
|
0
|
$207.99 | -$80,800,259.91 | 3.42M |
Oct 30
| |||
Form 4
| -2.14% | -5.55K |
—
|
—
| 253.34K |
Jul 11
| |||
Form 4
| -15.69% | -48.17K |
—
|
—
| 258.88K |
May 23
| |||
Form 4
| -37.08% | -180.93K |
—
|
—
| 307.05K |
Apr 4
| |||
Form 4
| -1.35% | -6.70K |
—
|
—
| 487.98K |
Feb 20
| |||
Form 4
| -3.69% | -18.95K |
—
|
—
| 494.68K |
Feb 11
| |||
Form 4
| +18.19% | 267.97K |
$7.86 | $2,106,212.76 | 1.74M |
Oct 3
| |||
Form 4
| +24.10% | 286.16K |
$5.60 | $1,602,512.80 | 1.47M |
Jan 6
| |||
Form 4
| -100.00% | -522.50K |
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1.80% | 45K |
$45.00 | $2,025,000.00 | 2.55M |
Sep 16 - Sep 17
| |||
Form 4
| +28.19% | 550K |
$20.00 | $11,000,000.00 | 2.5M |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +20.20% | 400K |
$17.50 | $7,000,000.00 | 2.38M |
Oct 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Tyra Biosciences, Inc. (TYRA) Snapshot price: $18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +281.49% | 63.41K |
$13.01 | $824,990.12 | 85.94K |
Feb 6
| |||
Form 4
| -92.18% | -265.57K |
$13.17 | -$3,498,611.20 | 22.53K |
Feb 9 - Feb 10
| |||
Form 4
|
∞
| 6.61M |
$16.00 |
—
| 6.61M |
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |